|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsu PC, Tian B, Yang YL, Wang YC, Liu S,
Urisman A, Yang CT, Xu Z, Jablons DM and You L: Cucurbitacin E
inhibits the Yes-associated protein signaling pathway and
suppresses brain metastasis of human nonsmall cell lung cancer in a
murine model. Oncol Rep. 42:697–707. 2019.PubMed/NCBI
|
|
5
|
Imakita T, Matsumoto H, Hirano K, Morisawa
T, Sakurai A and Kataoka Y: Impact on prognosis of rebiopsy in
advanced non-small cell lung cancer patients after epidermal growth
factor receptor-tyrosine kinase inhibitor treatment: A systematic
review. BMC Cancer. 19:1052019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hamard C, Mignard X, Pecuchet N, Mathiot
N, Blons H, Laurent-Puig P, Leroy K, Lupo A, Chapron J, Giraud F,
et al: IHC, FISH, CISH, NGS in non-small cell lung cancer: What
changes in the biomarker era? Rev Pneumol Clin. 74:327–338.
2018.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang L, Li Z and Wang R: Long noncoding
RNAs in lung cancer: Regulation patterns, biologic function and
diagnosis implications (Review). Int J Oncol. Jul 29–2019.(Epub
ahead of print). View Article : Google Scholar
|
|
9
|
Lim LJ, Wong SYS, Huang F, Lim S, Chong
SS, Ooi LL, Kon OL and Lee CG: Roles and regulation of long
non-coding RNAs in hepatocellular carcinoma. Cancer Res. Jul
23–2019.(Epub ahead of print). View Article : Google Scholar
|
|
10
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dai SP, Jin J and Li WM: Diagnostic
efficacy of long non-coding RNA in lung cancer: A systematic review
and meta-analysis. Postgrad Med J. 94:578–587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu T, Wang Y, Chen D, Liu J and Jiao W:
Potential clinical application of lncRNAs in non-small cell lung
cancer. Onco Targets Ther. 11:8045–8052. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang C, Yang Y, Yang Y, Guo L, Huang J,
Liu X, Wu C and Zou J: Long noncoding RNA (lncRNA) HOTAIR affects
tumorigenesis and metastasis of non-small cell lung cancer by
upregulating miR-613. Oncol Res. 26:725–734. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Y, Ni R, Wang J and Liu Y: Knockdown
of lncRNA DLX6-AS1 inhibits cell proliferation, migration and
invasion while promotes apoptosis by downregulating PRR11
expression and upregulating miR-144 in non-small cell lung cancer.
Biomed Pharmacother. 109:1851–1859. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Li P, Zhao W, Yang R, Chen S, Bai Y,
Dun S, Chen X, Du Y, Wang Y, et al: Expression of long non-coding
RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int. 15:482015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun W, Zhang L, Yan R, Yang Y and Meng X:
LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration
of non-small cell lung cancer cells by targeting the
miR-27b-3p/GSPT1 axis. Onco Targets Ther. 12:3945–3954. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng X, Hu Z, Ke X, Tang H, Wu B, Wei X
and Liu Z: Long noncoding RNA DLX6-AS1 promotes renal cell
carcinoma progression via miR-26a/PTEN axis. Cell Cycle.
16:2212–2219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, He X, Jin T, Gang L and Jin Z:
Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma
carcinogenesis by modulating miR-203a/MMP-2 pathway. Biomed
Pharmacother. 96:884–891. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li D, Tang X, Li M and Zheng Y: Long
noncoding RNA DLX6-AS1 promotes liver cancer by increasing the
expression of WEE1 via targeting miR-424-5p. J Cell Biochem.
120:12290–12299. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu DM, Zheng ZH, Zhang YB, Fan SH, Zhang
ZF, Wang YJ, Zheng YL and Lu J: Down-regulated lncRNA DLX6-AS1
inhibits tumorigenesis through STAT3 signaling pathway by
suppressing CADM1 promoter methylation in liver cancer stem cells.
J Exp Clin Cancer Res. 38:2372019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou FR, Pan ZP, Shen F, Huang LQ, Cui JH,
Cai K and Guo XL: Long noncoding RNA DLX6-AS1 functions as a
competing endogenous RNA for miR-577 to promote malignant
development of colorectal cancer. Eur Rev Med Pharmacol Sci.
23:3742–3748. 2019.PubMed/NCBI
|
|
23
|
An Y, Chen XM, Yang Y, Mo F, Jiang Y, Sun
DL and Cai HH: LncRNA DLX6-AS1 promoted cancer cell proliferation
and invasion by attenuating the endogenous function of miR-181b in
pancreatic cancer. Cancer Cell Int. 18:1432018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J, Ye Z, Mei D, Gu H and Zhang J:
Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating
miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.
Cancer Manag Res. 11:4209–4221. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Zhang H and Wu X: Long noncoding RNA
DLX6-AS1 accelerates the glioma carcinogenesis by competing
endogenous sponging miR-197-5p to relieve E2F1. Gene. 686:1–7.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang RM, Tang T, Yu HM and Yao XD: LncRNA
DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma
through Wnt signaling. Biochem Biophys Res Commun. 507:260–266.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang N, Meng X, Mei L, Zhao C and Chen W:
LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in
osteosarcoma through modulating miR-641/HOXA9 signaling pathway. J
Cell Biochem. Mar 6–2019.(Epub ahead of print).
|
|
28
|
Wei L, Wu W, Han L, Yu W and Du Y: A
quantitative analysis of the potential biomarkers of non-small cell
lung cancer by circulating cell-free DNA. Oncol Lett. 16:4353–4360.
2018.PubMed/NCBI
|
|
29
|
Jhun BW, Lee KJ, Jeon K, Suh GY, Chung MP,
Kim H, Kwon OJ, Sun JM, Ahn JS, Ahn MJ, et al: Clinical
applicability of staging small cell lung cancer according to the
seventh edition of the TNM staging system. Lung Cancer. 81:65–70.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang X, Hu J, Zhong L, Wang N, Yang L,
Liu CC, Li H, Wang X, Zhou Y, Zhang Y, et al: Quercetin stabilizes
apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
Neuropharmacology. 108:179–192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan G, Du Q, Wei X, Miozzi J, Kang C, Wang
J, Han X, Pan J, Xie H, Chen J and Zhang W: Application of
real-time cell electronic analysis system in modern pharmaceutical
evaluation and analysis. Molecules. 23:E32802018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jakobsen KR, Paulsen BS, Baek R, Varming
K, Sorensen BS and Jorgensen MM: Exosomal proteins as potential
diagnostic markers in advanced non-small cell lung carcinoma. J
Extracell Vesicles. 4:266592015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Duan W, Yan S, Xie Y and Wang C:
Circulating long non-coding RNA colon cancer-associated transcript
2 protected by exosome as a potential biomarker for colorectal
cancer. Biomed Pharmacother. 113:1087582019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li C, Lv Y, Shao C, Chen C, Zhang T, Wei
Y, Fan H, Lv T, Liu H and Song Y: Tumor-derived exosomal lncRNA
GAS5 as a biomarker for early-stage non-small-cell lung cancer
diagnosis. J Cell Physiol. 234:20721–20727. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cheng Y, Dai X, Yang T, Zhang N, Liu Z and
Jiang Y: Low long noncoding RNA growth arrest-specific transcript 5
expression in the exosomes of lung cancer cells promotes tumor
angiogenesis. J Oncol. 2019:24761752019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tang Q, Ni Z, Cheng Z, Xu J, Yu H and Yin
P: Three circulating long non-coding RNAs act as biomarkers for
predicting NSCLC. Cell Physiol Biochem. 37:1002–1009. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1
protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang W, Cai X, Yu J, Lu X, Qian Q and
Qian W: Exosome-mediated transfer of lncRNA RP11838N2.4 promotes
erlotinib resistance in non-small cell lung cancer. Int J Oncol.
53:527–538. 2018.PubMed/NCBI
|
|
41
|
Lei Y, Guo W, Chen B, Chen L, Gong J and
Li W: Tumor-released lncRNA H19 promotes gefitinib resistance via
packaging into exosomes in nonsmall cell lung cancer. Oncol Rep.
40:3438–3446. 2018.PubMed/NCBI
|
|
42
|
Mathieu M, Martin-Jaular L, Lavieu G and
Théry C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
